Anna Buda

Title: **Innovator Spotlight: Anna Buda**

Introduction

Anna Buda is a talented inventor based in Cracow, Poland. Her work has contributed significantly to the field of pharmaceutical sciences, particularly by focusing on innovative compounds with potential therapeutic applications. With her inventive spirit and dedication, she holds a notable patent that showcases her expertise in medicinal chemistry.

Latest Patents

Anna Buda is credited with one patent titled "Derivatives of quinoline as inhibitors of DYRK1A and/or DYRK1B kinases." This invention relates to a compound represented by formula (I) and includes its salts, stereoisomers, tautomers, or N-oxides. Furthermore, the patent focuses on the use of such compounds as medicaments and outlines a pharmaceutical composition comprising these innovative compounds.

Career Highlights

Throughout her career, Anna has worked with reputable companies in the pharmaceutical industry. Notable employers include Felicitex Therapeutics, Inc. and Selvita S.A. Her professional experiences in these organizations have allowed her to develop valuable skills and contribute to advancing drug discovery processes.

Collaborations

In her journey as an inventor, Anna Buda has collaborated with notable individuals in her field, including Agnieszka Dreas and Charles-Henry Fabritius. These partnerships have played a role in her success and the development of her renowned patent.

Conclusion

Anna Buda exemplifies the spirit of innovation within the pharmaceutical industry. With her patented work on quinoline derivatives and her collaborations with esteemed colleagues, she continues to make significant strides in the realm of medicinal chemistry. Her contributions hold promise for future advancements in therapeutic solutions, making her an inspiring figure in the landscape of inventions and innovations.